Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +38.35%
#3 Glidr Glidr +36.87%
#4 Humanity Humanity +28.61%
#5 Collector Crypt Collector Crypt +19.82%
#6 Walrus Walrus +18.37%
#7 Codatta Codatta +18.00%
#8 Provenance Blockchain Provenance Blockchain +16.83%
#9 Enso Enso +15.35%
#10 The Black Bull The Black Bull +14.70%
Coin of the day
EXOD EXOD
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Peringkat dalam Saham #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Harga Saham
$0.117
Terakhir disinkronkan: 2025-04-04
Kapitalisasi Pasar
$2.45M
Perubahan (1 hari)
-13.59%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Carmell Therapeutics Corporation (CTCX)

Kategori

Healthcare
Pendapatan untuk Carmell Therapeutics Corporation (CTCX)
Pendapatan pada Jun 2026 TTM: $1.69M
Menurut laporan keuangan terbaru dari Carmell Therapeutics Corporation, pendapatan saat ini (TTM) adalah $1.69M. Pada tahun 2023, perusahaan menghasilkan pendapatan sebesar 0.00 sama dengan pendapatan pada tahun 2022 yang sebesar 0.00. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Carmell Therapeutics Corporation dari 2021 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Mengubah
2026 (TTM) $1.69M 3,251.88%
2024 $50.32K 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
Pendapatan untuk perusahaan serupa atau pesaing
Perusahaan Pendapatan Perbedaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 748,405.43%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 356,907.22%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 599,377.10%
BE